Clinical trial underway to investigate efficacy
Treats patients within 60 seconds
Challenges still need to be ironed out
Using software to offset the cost of conventional diagnostics
New tool automatically answers referring clinicians' questions
Prototype for animal testing in the works
Researchers find sufficient evidence to support routine screening
Machine learning will be a major focus
May increase disease-free survival
Creating deep learning algorithms for the clinical lab
Legislation would mandate Medicare coverage of the exam
40 percent of ER patients are eligible
Budget-friendly system does more with advanced applications
May detect heart attack and stroke before symptoms occur
The Magnetom Vida with BioMatrix technology is on display at ECR
Bioabsorbable screws may be alternative to metallic implants
A patient-friendly alternative to liver biopsy
Evidence shows no benefits in renal function, significant costs
How virtual reality can make surgery less invasive
PET tracer may improve CAD detection with less dose exposure than SPECT
Applications abound, but lack of training stands in the way
Reducing the variables in radiation exposure
Penn expert calls for hypofractionated treatment
Study shows promise for synthesized mammo based on tomo exam
It isn't just for those at high risk, finds new study
Managed service for hospital-wide health care informatics
Checking in with the rapid evolution of stent technology
Turning big data into smart data
MR-compatible pacemakers are a major driver
More accurate than conventional methods
Researchers gain insight into the psychology of late-life cognitive decline
Patients need to be carefully monitored
Costs will exceed $1 trillion annually
Iron oxide nanoparticle safe for patients with kidney failure
Single-fraction RT may close treatment gap
High-growth medical aesthetics segment valued at $2 billion
Bringing 10-minute brain scans to small practices
Conventional radiological techniques weren't cutting it
'Organ on a chip' can be used to predict drug response
Phase III clinical trial of [F-18]MK-6240 slated for 2018
CT images were used to create model
Greater outreach and education needed for these patients
Stringent eligibility criteria may be more cost-effective
May have implications for newly diagnosed patients and survivors
May eliminate need for pathologist review
Allows breast MR exams at a tenth of the conventional cost
May also help in targeting treatment
Workshop sheds light on key issues hospitals must address
Not everyone is convinced of controversial findings
Screening can start at age 30 instead of 65